Bicara Therapeutics Inc. 10-K filing
Filed 2026-03-30 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001628280-26-022010
- Form type
- 10-K
- CIK
- 0002023658
- Primary document
- https://www.sec.gov/Archives/edgar/data/2023658/000162828026022010/bcax-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Bicara Therapeutics Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-155.6M | - | - |
| Net Income | $-137.9M | - | - |
| Eps Basic | -2.52 | - | - |
| Eps Diluted | -2.52 | - | - |
| Cash And Equivalents | $96.7M | - | - |
| Total Assets | $431.0M | - | - |
| Total Liabilities | $29.5M | - | - |
| Shareholders Equity | $401.5M | - | - |
| Operating Cash Flow | $-106.8M | - | - |
| Capital Expenditures | $280,000 | - | - |